COMMUNIQUÉS West-GlobeNewswire

-
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
08/07/2025 -
Jade Biosciences to Participate in Two Upcoming Investor Conferences
08/07/2025 -
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
08/07/2025 -
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
08/07/2025 -
BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer
08/07/2025 -
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
08/07/2025 -
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies
08/07/2025 -
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
08/07/2025 -
iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.
08/07/2025 -
Vaxart Announces Trading on OTCQX Best Market
08/07/2025 -
Medvantx Acquires RxS to Broaden Integrated Access & Engagement Solutions for Life Science
08/07/2025 -
Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP
08/07/2025 -
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
08/07/2025 -
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
08/07/2025 -
Certara Announces Expansion of Clinical Technology Collaboration with Merck
08/07/2025 -
Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars
08/07/2025 -
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
08/07/2025 -
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
08/07/2025 -
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
08/07/2025
Pages